Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, December 16, 2021
Viroclinics-DDL, employing a total of over 390 scientists and experts, offers a broad range of virology related services in the field of non-clinical and clinical trials, clinical diagnostics, assay development and clinical trial logistics enabling ...
read more
Centinel Spine® announced FDA approval for the manufacturing transfer of both the prodisc® C Cervical Total Disc Replacement and prodisc® L Lumbar Total Disc Replacement systems to new vendors.
read more
Celonic announced a long-term lease agreement for a new production site and office space spanning 91,500 square feet in the WST-222 building at the Novartis-operated Life Science Park Rheintal.
read more
CellPoint, a cell therapy company developing CAR-T therapeutics for use at the point-of-care, announces an agreement with Lonza's Personalized Medicine Business Unit to employ Lonza's Cocoon® Platform for clinical manufacturing of CellPoint's CAR-T ...
read more
CellGenix GmbH has announced the completion of the second phase of their facility expansion.
read more
Wednesday, February 07, 2018
Golden Meditech announced its associate, Cellenkos successfully registered its stand-alone, manufacturing facility as GMP compliant with FDA.
read more
Wednesday, October 02, 2019
Cellectis and Lonza announced the companies have entered into a manufacturing service agreement covering clinical manufacturing of Cellectis’ allogeneic UCART product candidates targeting hematological malignancies.
read more
Cellectis has entered into a lease agreement to build an 82,000 square foot commercial-scale manufacturing facility named IMPACT in Raleigh, North Carolina.
read more
Tuesday, December 14, 2021
CellCarta, a global provider of precision medicine laboratory services, announced the acquisition of Biogazelle ("Biogazelle"), a leader in genomic testing solutions. Located in Ghent (Belgium), Biogazelle develops and deploys high-end digital PCR (...
read more
Wednesday, April 06, 2022
Celerion, a clinical research organization (CRO) to the biopharmaceutical industry, announced that it has made a significant investment in its ADME (Absorption, Distribution, Metabolism and Excretion) suite of services to meet continuously increasing...
read more
CEL-SCI has signed a collaboration agreement with the University of Georgia’s Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy.
read more
Thursday, November 08, 2012
Cedarburg Hauser Pharmaceuticals (CHP), an experienced contract development and manufacturing organization (CDMO), has announced the appointment of John K. Lynch, Ph.D. as its Chief Scientific Officer (CSO).
read more
The Wasdell Group has secured a new contract to supply medicines and dietary supplements directly to consumers from its Swindon, UK, site.
read more
Spray drying and capsule filling service provider Micro-Sphere is investing €19 million into expanding its GMP manufacturing capabilities at its facility in Switzerland.
read more
Monday, November 23, 2020
CCRM and MIP have signed a LOI to partner in the development of a biomanufacturing campus at MIP focused on regenerative medicine-based technologies and cell and gene therapies.
read more